Research Progress on Bioactive Metal Complexes against ER-Positive Advanced Breast Cancer-Reference-Cited by-同舟云学术

Research Progress on Bioactive Metal Complexes against ER-Positive Advanced Breast Cancer

Published:2023-02-13 Issue:4 Volume:66 Page:2235-2256
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Liang Zhenlin¹,Liu Lijuan¹,Zhou Yanyu¹,Liu Wukun¹²^ORCID,Lu Yunlong¹

Affiliation:

1. Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, P. R. China

2. State key Laboratory of Coordination Chemistry, Nanjing University, Nanjing, 210023, P. R. China

Funder

Nanjing University of Chinese Medicine

Jiangsu Provincial Department of Education

National Natural Science Foundation of China

Jiangsu Commission of Health

Priority Academic Program Development of Jiangsu Higher Education Institutions

State Key Laboratory of Coordination Chemistry (Nanjing University)

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01458

Reference115 articles.

1. Cancer statistics, 2019

2. ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

4. Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential

5. Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and Antagonist

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the cytotoxicity of a new gold(I) complex towards hepatocellular carcinoma by inhibiting TrxR activity;Acta Biochimica et Biophysica Sinica;2024-09-01

2. SCARB2 associates with tumor-infiltrating neutrophils and predicts poor prognosis in breast cancer;Breast Cancer Research and Treatment;2024-06-24

3. Dual-target inhibitors based on ERα: Novel therapeutic approaches for endocrine resistant breast cancer;European Journal of Medicinal Chemistry;2024-04

4. Comparative Solution Equilibrium Studies on Anticancer Estradiol-Based Conjugates and Their Copper Complexes;Inorganics;2024-02-01

5. Design and synthesis of phosphoryl-substituted steroidal pyridazines (Pho-STPYRs) as potent estrogen receptor alpha inhibitors: targeted treatment of hormone-dependent breast cancer cells;RSC Medicinal Chemistry;2024